INTRODUCTION
We found that small peptides (tentatively named erythrotropins) isolated from bovine fetal tissues stimulated thymidine incorporation and haemoglobin synthesis in fetal calf erythroid cells [1] . The isolation and characterization of these peptides indicated that they belonged to the insulin-like growth factor (IGF) family. The most abundant of these peptides in fetal bovine serum was isolated and sequenced and it corresponded to the sequence of bovine IGF II [2, 3] . Our results and those of many other investigators indicate that both IGF I and II play an important role in erythropoiesis in vitro [4] [5] [6] [7] [8] [9] [10] and in vivo [11, 12] . Therefore IGFs may be useful as therapeutic agents in anaemia and generally as anabolic hormones in diseases where growth hormone may be ineffective or have undesirable side effects [13, 14] .
IGFs are particularly attractive as targets for site-directed mutagenesis because they are small non-glycosylated peptides which have multiple binding sites with a large number of proteins. For instance, it is possible to decrease the binding activity to serum binding proteins without affecting the binding affinity to IGF receptors [15, 16] . Therefore they are exceptional compared with the vast majority of growth factors in the sense that mutagenesis can actually result in a higher biological activity [17] . It would be a great advantage if IGFs could be synthesized with the baculovirus expression system, which is known for being able to produce large amounts of mammalian proteins. Unfortunately, when the IGF II precursor was integrated into the baculovirus, although it was expressed, it resulted in a protein that was not processed or secreted [18] . Alternatively, IGF II has been synthesized as a baculovirus fusion protein [19] . In the present paper we show how a chimaera of IGF II and the Nterminal sequence of the gene encoding the insulin-like peptide bombyxin is correctly processed and secreted in the baculovirus amino acids of bombyxin and the 58 C-terminal amino acids of IGF II. The N-terminal glutamine of bombyxin was changed to asparagine to facilitate sequencing of the synthetic peptide. The chimaera was five times more potent than human recombinant IGF II in its capacity to stimulate thymidine incorporation into erythroid cells of fetal bovine liver in a serum-free medium. It stimulated erythroid colony formation in the presence of 2 munits/ml erythropoietin in cells cultured over a monolayer of stromal cells of fetal liver. Artificial chimaeras as described here may prove useful for the production of insulin, IGF I Figure 1 was synthesized by the method of Dillon and Rosen [20] . Four sense and antisense strands indicated by arrows in Figure 2 (reaction 1) and containing 84, 84, 84 and 88 nucleotides with overlapping sequences of 18 nucleotides were joined with Taq polymerase as illustrated. The gene was amplified with Taq polymerase using two oligonucleotide primers which contained the NheI restriction sites required for the ligation with the pBluebac transfer vector from Invitrogen ( Figure 2 , reaction 2). The synthetic gene ( Figure  1 ) contained the signal peptide of bombyxin (amino acids -19 to -1) and the first ten amino acids of bombyxin [21] with two Abbreviations used: IGF, insulin-like growth factor; AcNPV, Autographa californica nuclear polyhedrosis virus; BOMIGF, Asn-Gln-Pro-Gln-Met-ValHis-Thr-Tyr-human IGF 11-(9-67); Ac[BOMIGF], recombinant baculovirus in which the signal peptide of bombyxin+BOMIGF (Figure 1) Figure 1 Sequence of the chimaera of bombyxin and IGF 11
The amino acid sequence and corresponding nucleotide sequence utilized for the synthesis of the synthetic gene are shown. Amino acids -19 to 10 correspond to the signal peptide and the N-terminal section of bombyxin [21] with the exception of amino acids 1 (Asn) and 5 (Met) indicated in boxes. Amino acids 10-68 correspond to amino acids 9-67 of human IGF II [22, 23] . A termination codon (TAG) followed the C-terminal amino acid (Glu). Accurate processing [21] should result in the synthesis of BOMIGF, amino acids 1-8. modifications, namely replacement of amino acids 1 (Gln to Asn) and 5 (Glu to Met). Amino acid 10 (Cys) was common to both bombyxin and human IGF II, and amino acids 10-68 corresponded to residues 9-67 of mature human IGF II [22, 23] . A termination codon (TAG) followed immediately after the Cterminal glutamic acid. The product of the amplification reaction was ligated with the TA cloning kit of Invitrogen to pCRIOO0 ( Figure 2 , reaction 3), and the entire sequence was confirmed with the Sequenase sequencing kit (US Biochemicals, Cleveland, OH, U.S.A.). The plasmid was digested with NheI and ligated to the pBluebac transfer vector (Figure 2 , reaction 4), which was originally created by Vialard et al. [24] and contains the Lac gene for identification of recombinants by blue colour selection. Positive clones were selected using lifts of bacterial colonies showing hybridization with the bombyxin-IGF II probe by standard techniques [25] . Several clones were sequenced (Circumvent kit, New England Biolabs) to confirm the integrity and correct orientation of the insert after the polyhedrin promoter.
Clones that showed 1000% identity after sequencing with the Vent polymerase (New England Biolabs) and with the accurate orientation within the polyhedrin promoter were co-transfected ( Figure 2 , reaction 5) with the wild-type linearized genomic Autographa californica nuclear polyhedrosis virus (AcNPV) baculovirus using the calcium phosphate precipitation method [26] .
Successful recombination was followed using 5-bromo-4-chloro-3-indolyl /-D-galactopyranoside in the transfection medium as an indicator of the marker enzyme f-galactosidase [27] . Serial dilutions of the transfection supernatants were prepared and used to infect Sf9 cells plated in tissue culture dishes of 6 cm diameter. The infected cells were covered with agarose and the formation of blue plaques was followed for several days [27] . The process of screening for recombinants was as follows: (1) identification and collection of agarose plugs from blue plaques; (2) expansion of the viral plaques in Sf9 cells plated in 3.5-cm dishes; (3) identification of positive recombinants by dot hybridization using IGF II probes [3] ; (4) extraction of DNA from positive recombinants from 750 ,1 supernatants to be used for PCR employing as primers 5' and 3' flanking regions of the polyhedrin gene, as indicated in the Invitrogen kit.
The production of the recombinant protein was assessed first by PAGE of cell extracts and cell culture supernatants using the Tris/Tricine system [28] followed by electroblotting to poly(vinylidene fluoride) membranes (Immobilon; Millipore, Marlborough, MA, U.S.A.) and Western blotting using an IGF II antibody (UBI Biotechnologies, Lake Placid, NY, U.S.A.). However, this method was not as sensitive and specific as required for an unequivocal identification. The protein bands with the expected molecular mass were faint, and sometimes the interpretation of the results was ambiguous because of the presence of other positive proteins. These problems are probably due to artifacts caused by the SDS denaturation step. Therefore the best method of identification turned out to be measurement of the ability of supernatants of the infected cells to stimulate thymidine incorporation into calf erythroid cells [29] . This method is not necessarily specific for IGF II [4, 29] but has the advantage of being able to detect very small amounts of this growth factor. Furthermore, only recombinants producing biologically active peptides are selected. Sf9 cells (2.8 x 10f were plated in 6 cm Lux-contour cell culture dishes [27] and infected with the recombinant viruses in Sf900 serum-free medium (Gibco). After 2-3 days, the supernatants and cells were separated by centrifugation. Supernatants were acidified with trifluoroacetic acid to a final concentration of 1 % (v/v) and extracted by reversed-phase h.p.l.c. using C18 cartridges (Sep-Pak; Millipore) as previously described [30] . The cells were lysed in 3 ml of acid- acid to a final concentration of 1 % (v/v) and extracted by reversed-phase h.p.l.c. as indicated above using one cartridge per 25 ml of medium. The extract was concentrated and applied to two Waters 1-125 columns attached in series [30] . Several identical separations were required to process the complete extract. Fractions corresponding to molecular masses of 5-14 kDa were pooled, concentrated and applied to a Vydac C4 semipreparative column (1 cm x 25 cm). They were eluted at a speed of 2 ml/min using a gradient of solution A [water/acetonitrile/trifluoroacetic acid (99: 1:0.1 by vol.)] to solution B [water/acetonitrile/ trifluoroacetic acid (20:80:0.1, by vol.)] as follows: 10 min from 0 to 25 % B, 30 min from 25 to 45 % B and 20 min from 45 to 80 % B. Portions of volume 15 ,u were taken, evaporated and tested for biological activity using the bioassay of calf liver erythroid cells as indicated above. Fractions with thymidineincorporation-stimulating activity were pooled and applied to four Waters 1-125 gel-filtration columns attached in series and eluted at a speed of 0.6 ml/min. Fractions with thymidineincorporation-stimulating activity were pooled and applied to a Brownlee Aquapore column of 10 cm long preceded by a similar precolumn 3 cm long. The peptides were eluted at a speed of 0.3 ml/min using a gradient between solutions A and B as follows: 10 min from 0 to 22 % B, 10 min from 22 to 38 % B and 10 min from 38 to 55 % B. A single peak of absorbance eluted at 24 min contained the fractions with biological activity, as indicated in the thymidine-incorporation assay. Samples were used for amino acid analysis (Beckman 6300 amino acid analyser), Nterminal sequencing (Sheldon Biotechnology Centre, McGill University) and electrophoresis in precast gels (high-density SDS/PAGE; Phastsystem, Pharmacia, Baie d'Urfe, Quebec, Canada). extraction mixture [1, 30] , sonicated for 2 min and extracted as indicated for the supernatants. The extracts were lyophilized (Speedvac centrifuge; Savant, Fisher Scientific, Montreal, Quebec, Canada), suspended in modified, serum-free F12 medium [29] and tested for their capacity to stimulate thymidine incorporation into calf erythroid cells [29] . The modified F12 medium was later replaced with a mixture of F12/Iscove's modified Dulbecco's medium (IMDM) (3: 1, v/v) supplemented with 100 ,uM a-thioglycerol, 10 ,ug/ml gentamicin and 30 ,tg/ml bovine transferrin (ICN, Richmond, CA, U.S.A.).
Production and purffication of the recombinant protein A typical preparation was as follows. Sf9 cells (2 x 108 in 200 ml of suspension culture) were infected in Sf900 serum-free medium with the recombinant baculovirus as a multiplicity of infection of 14 as indicated by Piwnica-Worms [27] . At 3 days after infection the suspensions were centrifuged at 300 g for 10 methylcellulose, 2% (v/v) fetal bovine serum, 60,ug/ml transferrin, 8 ,ug/ml cholesterol, 5.6 ,tg/ml oleic acid, 8 ,ug/ml L-aphosphatidylcholine, 0.3 ,tg/ml vitamin A, 0.33 ,ug/ml vitamin E, 130 ,tg/ml haemin, 30 % F12 medium, 100 nM a-thioglycerol and 2 munits/ml recombinant erythropoietin. IGF II or the recombinant BOMIGF was added at a final concentration of 500 ng/ml. After 72 h, the number of erythroid colonies was counted in a phase-contrast microscope.
RESULTS AND DISCUSSION

Construction of a recombinant baculovirus encoding a bombyxin-human IGF 11 chimaera
The baculovirus expression system has been successfully used for the synthesis of a large variety of mammalian proteins. Insect cells have the possibility of recognizing many mammalian signals for the processing and intracellular localization of proteins driven by the polyhedrin promoter of the virus [31, 32] . The polyhedrin protein normally accounts for 30 % of the total proteins synthe- The insulin family of peptides represents one of the most conserved protein structures during evolution. There are insulinrelated peptides in Locusta migratoria [34] and in the neurosecretory cells of the silkworm [21] . It is therefore reasonable to assume that the signal sequences of these insect insulin-like peptides may be used for the synthesis of mammalian insulins or IGFs. We were particularly interested in bombyxins, the insulinlike peptides of the silkworm, because Adachi et al. [21] have found that the precursor of these peptides closely resembles mammalian proinsulins. Therefore we synthesized a chimaera between the signal peptide of bombyxin and the human IGF II gene (Figure 1 ), using the method of Dillon and Rosen [20] . We were particularly interested in recognizing the accurate processing of the synthetic chimaera by protein sequencing. Therefore we changed the N-terminal glutamine of natural bombyxin to asparagine. This modification prevents the pyroglutamic acid formation observed in bombyxin and therefore the subsequent blockage of the N-terminal synthetic IGF. It is possible that the processing enzymes in insect cells may require the presence of certain amino acids within the N-terminal section of the mature proteins. Therefore we decided to keep the first 10 amino acids of bombyxin in the synthetic gene. It is reasonable to assume that replacement of the N-terminal IGF II amino acid sequence with that of bombyxin should not alter the biological activity of this growth factor, because it is known that this section of the molecule is not essential for receptor binding [17, 35] . On the contrary, elimination of potential binding sites in this region of IGFs with plasma IGF-binding proteins eventually increases the biological activity of the synthetic peptide, as has been demonstrated with recombinant IGF I analogues obtained by sitedirected mutagenesis [17] . We introduced an additional mutation into the N-terminal region of the synthetic peptide, namely a methionine at position 5 peptide by CNBr treatment. This unique methionine would also be useful if the insect sequences of the chimaera were found to induce an immune response in vivo, because the five N-terminal amino acid residues could be eliminated by CNBr treatment.
The synthetic chimaera of Figure 1 was ligated into the TA cloning vector pCR1OOO. This allowed us to confirm the sequence and to eliminate clones with mismatches known to occur using Taq polymerase. At the same time, it facilitated digestion with the restriction enzyme NheI, because amplified DNA with restriction sites at the 3' and 5' ends are poorly digested [36] . After integration of correctly amplified genes into the pBluebac vector of Vialard et al. [24] , the sequence and correct orientation of the inserted DNA were further confirmed using the Vent polymerase sequencing kit as indicated in the Materials and methods section. Recombinant viruses were made and selected as described above and the recombinant viral stocks amplified. The recombinant baculovirus selected here from a pure plaque was 6.5 3 
Figure 7 SDS/PAGE of the purffied BOMIGF
The fractions eluted at 24 min during the reversed-phase h.p.l.c. shown in Figure 6 were applied to a high-density gel (Pharmacia) and separated by electrophoresis using the Phastsystem. The arrows and numbers indicate the positions of the molecular-mass markers in kDa (Rainbow lowmolecular-mass markers; Amersham). The gel was stained with silver.
named Ac [BOMIGF] . Figure 3 shows the production of a factor with thymidine-incorporation-stimulating activity in the supernatants of Sf9 insect cell cultures after infection with Ac [BOMIGF] . Note that all the activity is present in the supernatant, and practically no activity could be observed in cell extracts. Supernatants of mock-infected cells or cells infected with the wild-type baculovirus AcNPV did not have any thymidine-incorporation-stimulating activity (results not shown). This very sensitive bioassay was used for the purification and selection of positive recombinants.
Purffication of the bombyxin-IGF 11 chimaera (BOMIGF)
We have purified the recombinant protein on a semipreparative scale from batches of 150-200 ml of serum-free medium obtained from suspension cultures of cells infected by the baculovirus. The initial purification was a reversed-phase chromatography followed by gel filtration as indicated in the Materials and methods section. The most efficient purification step was the reversedphase chromatography using Vydac columns (Figure 4) , which eliminated most of the contaminating proteins. Further purification steps, such as gel-filtration h.p.l.c. (Figure 5 ) and reversedphase h.p.l.c. using Aquapore columns (Figure 6 ), resulted in a single peptide as analysed by SDS/PAGE (Figure 7) . The apparent molecular mass was between 6 kDa (SDS/PAGE) and Erythropoietic activity of BOMIGF The erythropoietic activity of the recombinant protein was evaluated by two methods. The first involved measurement of the protein's capacity to stimulate thymidine incorporation into erythroid cells offetal calfliver (Figure 8a ). Incubation conditions were as indicated in the original bioassay [29] , but total incubation volume was reduced to 100 ,1 and the number of cells was only Figure 8a ). Nevertheless, they are about ten times lower then the physiological concentrations of IGF II in cord blood [37] . BOMIGF and IGF II had similar effects in the stimulation of erythroid colony formation in the presence of erythropoietin and monolayers of fetal liver cells (Figure 8b ), as required for the action of IGFs in bovine fetal liver. However, this culture system is difficult to evaluate quantitatively, because it is not completely serum-free and requires the presence of erythropoietin and stromal cells (Q. Li and L. F. Congote, unpublished work). We are at present modifying the BOMIGF-pBluebac vector by sitedirected mutagenesis with the hope of obtaining new chimaeras which could result in a higher erythropoietic activity. We think that the introduction of the bombyxin signal peptide as a tool for the synthesis of insulin and insulin-like peptides using the very efficient baculovirus system will eventually decrease the cost of production and facilitate the modification of these useful peptides by site-directed mutagenesis. We are also exploring the possible use of bombyxin chimaeras with peptides that do not belong to the insulin superfamily.
